Photodynamic Therapy For Recurred Subfoveal Choroidal Neovascularization After Argon-Laser Photocoagulation.
- Author:
Min Joung LEE
1
;
Su Jeong SONG
;
Hum CHUNG
;
Hyeong Gon YU
Author Information
1. Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. hgonyu@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Argon-laser photocoagulation;
Choroidal neovascularization;
Photodynamic therapy;
Recurrence;
Subfoveal
- MeSH:
Choroid*;
Choroidal Neovascularization*;
Fluorescein;
Fluorescein Angiography;
Humans;
Light Coagulation*;
Photochemotherapy*;
Recurrence;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2005;46(12):1989-1994
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the effects of photodynamic therapy for subfoveal recurrences of juxtafoveal or extrafoveal choroidal neovascularization (CNV), previously treated with argon-laser photocoagulation. METHODS: Seven eyes, previously treated with argon-laser photocoagulation for juxtafoveal or extrafoveal choroidal neovascularization, received photodynamic therapy for subfoveal recurrence. Changes in visual acuity and fluorescein angiographic findings were analyzed. RESULTS: The average time of appearance of recurrent CNV after laser photocoagulation was 43.14+/-29.62 months (range, 2-77 months). After photodynamic therapy, fluorescein leakage and neovascular lesion size decreased in all patients on fluorescein angiography. Visual acuity was stabilized or improved in 5 of 7 eyes. CONCLUSIONS: Photodynamic therapy was effective in patients with subfoveal recurrences of juxtafoveal or extrafoveal choroidal neovascularization previously treated with argon-laser photocoagulation.
